16 HOW SUPPLIED/STORAGE AND HANDLING
How Supplied
BOSULIF (bosutinib) tablets are supplied for oral administration in 3 strengths: a 100 mg yellow, oval, biconvex, film-coated tablet debossed with "Pfizer" on one side and "100" on the other; a 400 mg orange, oval, biconvex, film coated tablet debossed with "Pfizer" on one side and "400" on the other; and a 500 mg red, oval, biconvex, film-coated tablet debossed with "Pfizer" on one side and "500" on the other. BOSULIF (bosutinib) tablets are available in the following packaging configurations (Table 11):
BOSULIF Tablets | |||
---|---|---|---|
Package Configuration | Tablet Strength (mg) | NDC | Tablet Description |
Abbreviation: NDC=National drug code. | |||
120 tablets per bottle | 100 mg | 0069-0135-01 | Yellow, oval, biconvex, film-coated tablets, debossed "Pfizer" on one side and "100" on the other. |
30 tablets per bottle | 400 mg | 0069-0193-01 | Orange, oval, biconvex, film-coated tablet debossed with "Pfizer" on one side and "400" on the other. |
30 tablets per bottle | 500 mg | 0069-0136-01 | Red, oval, biconvex, film-coated tablets, debossed "Pfizer" on one side and "500" on the other. |